Register of Blood Stem Cell Transplantation
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Hematologic Malignancies. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Germany
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Register of Survey and Evaluation of Blood Stem Cell Transplantations of Clinic III of Internal Medicine III
Overview
Register of patients with blood stem cell transplantations (autologous, allogen).
Detailed description
Documenting the success rate in terms of complication rate, disease response, survival rate, engraftment, and details of transplantation settings, for example donor and conditioning data, remission status before transplantation.
It's a register of patients who have one or more autologous and / or allogenic blood stem cell transplants due to an existing indication for performing myeloablative / non-myeloablative high-dose chemotherapy.
The inclusion occurs at our center during preparation for blood stem cell transplantation. The written consent will be obtained separately in the context of the information on blood stem cell transplantation. Participation is voluntary and consent can be revoked at any time. This involves no additional effort for the patient and has no influence on his treatment. It may be necessary in the course of contacting the patient at home, as long as the data is incomplete. This is also explicitly explained. A copy of the declaration of consent is given to the patient.
Primary outcome measures
- Register of stem cell transplantation [Time frame: approximately over 20 years]
Secondary outcome measures (4)
- Register of toxicities [Time frame: approximately over 20 years]
- Register of complications [Time frame: approximately over 20 years]
- Register of morbidities [Time frame: approximately over 20 years]
- Register of survivals [Time frame: approximately over 20 years]
Eligibility criteria
Inclusion criteria
- signed IC
- patients eligible for stem cell transplantation
Exclusion criteria
- unable to consent to study participation
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
Germany · 1 center
- Klinikum rechts der Isar der TU München — Munich
Identifiers
NCT: NCT04263857 · REBB3M